Peptide profile · Healing & Recovery
BPC-157
The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.
Molecular formula
C62H98N16O22
- CAS number
- 137525-51-0
- PubChem
- 9941444
- Developed · 1992
- Predrag Sikirić, University of Zagreb
Amino acid sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val250 – 500mcg
Every documented dose level
| Phase | Dose | Frequency |
|---|---|---|
| Weeks 1-2 | 250 mcg | Once daily |
| Weeks 4-6 | 250-500 mcg | Twice daily |
| Weeks 6-8 | 500 mcg | Twice daily |
Best for injury recovery & post-surgery healing
Best for
Consider alternatives if
Do not use if
- Pregnancy
- Breastfeeding
- Active cancer
- History of cancer
Use with caution if
- You have any chronic medical conditions
- You are taking prescription medications
- You have a history of allergic reactions to peptides
Not sure?
Compare BPC-157 with similar peptides to find the best fit for your goals.
Route
Subcutaneous injection
Into the fatty tissue just under the skin.
Best sites
- Lower abdomen (2 inches from navel)
- Outer thigh (middle third)
- Back of upper arm
The BPC-157 injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.
3 common side effects · 2 serious
BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research.
Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data.
Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds.
Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.
BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. However, no completed Phase 3 human clinical trials exist.
Published human data is limited to a small number of early-phase studies and case reports. Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA .
Common side effects · experienced by some users
Injection site redness
Usually resolves in 30-60 minutes
Management
Rotate sites, ice if needed
Mild nausea
Typically only first few doses
Management
Take with food, reduce dose temporarily
Dizziness
Rare, usually with higher doses
Management
Reduce dose, stay hydrated
Serious side effects
Allergic reaction
Rare but serious allergic reactions may include difficulty breathing, facial swelling, or anaphylaxis. Seek immediate medical attention if experienced.
Management
This is a medical emergency. Call 911 or go to the nearest emergency room immediately. If you have an EpiPen available, use it. Stop BPC-157 use immediately and inform medical staff that you were using a peptide therapeutic compound.
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- If you experience severe or persistent injection site reactions or signs of infection
- If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash
- If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches
Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.
With other peptides
- SafeTB-500
- SafeGHK-Cu
- SafeCJC-1295 + Ipamorelin
With medications
- CautionBlood Thinners (Warfarin
- Cautionetc.)
- CautionNSAIDs (Ibuprofen
With supplements
- SafeVitamin D3 — Generally safe and may support overall health
- SafeMagnesium — Generally safe and may enhance peptide absorption
Strong preclinical · first signs week 1-2
Evidence level
Strong preclinical
(extensive animal studies)
70/100
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
The deeper mechanism
What to expect
Week 1-2
What you might notice
- Reduced inflammation
- Less pain at injury site
- Improved gut comfort (if used for digestive issues)
What's normal
- Subtle changes—don't expect dramatic results yet
- Some users feel nothing this early
What's next
- Continue protocol
- Maintain consistent timing
Week 3-4
What you might notice
- Noticeable improvement in injury healing
- Increased mobility
- Better function in affected area
- Significant gut symptom relief
What's normal
- This is when most users see clear benefits
- Progress may be gradual, not sudden
What's next
- Assess if dose adjustment needed
- Continue if seeing progress
Week 5-6+
What you might notice
- Substantial or complete healing
- Return to normal activity
- Lasting improvements
What's normal
- Healing timeline varies by injury severity
- Some chronic conditions need longer
What's next
- Consider stopping if healed
- Take 2-4 week break
- Can restart if needed
Signs it's working
For injuries
- Less pain at rest
- Less pain with movement
- Improved range of motion
- Faster recovery between workouts
- Reduced swelling
Signs it's working
For gut issues
- Less bloating
- Reduced pain after eating
- More regular digestion
- Decreased symptoms overall
Not seeing results?
Common reasons
- Not allowing enough time—most peptides require consistent use for weeks to months before full effects are apparent
- Inconsistent dosing schedule—maintaining regular administration is critical for optimal results
- Improper storage or handling leading to degraded product
- Individual variation in response—genetics, health status, and other factors affect how you respond
- Dose may need adjustment—consult with your healthcare provider about optimizing your protocol
2 registered studies, 1 still enrolling.
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 162 people took part in the studies that actually administered BPC-157. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
BPC 157 for Acute Hamstring Muscle Strain Repair
Hudson Biotech
PCO-02 - Safety and Pharmacokinetics Trial
PharmaCotherapia d.o.o.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when BPC-157 is named as an intervention; studies that only mention it in passing are not.
How long does BPC-157 take to work?
Most users begin noticing effects within 1-2 weeks, with significant improvements typically occurring around weeks 3-4. For severe or chronic injuries, it may take 6-8 weeks for full benefits.
Can I take BPC-157 orally?
While some research shows oral BPC-157 may be effective for gut issues, subcutaneous injection is generally preferred for systemic and localized healing as it provides more reliable absorption .
Should I inject near the injury site?
Injecting near the injury site can provide localized benefits, but BPC-157 also works systemically. Many users alternate between local and abdominal injections.
Can I stack BPC-157 with other peptides?
Yes, BPC-157 is commonly stacked with TB-500 for enhanced healing. It can also be used alongside growth hormone secretagogues without issues.
Do I need to cycle BPC-157?
Cycling is recommended. A typical protocol is 4-6 weeks on, followed by 2-4 weeks off before restarting if needed. This helps maintain effectiveness and allows assessment of healing progress.
History · since 1993
The healing peptide that fixes damaged tissue from the inside
Pentadecapeptide is a 15-amino acid peptide that acts like your body's repair crew. It helps heal wounded tissues, strengthens joints, and fixes damaged gut linings.
Read the full history of BPC-157Studied for
Goal protocols
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for BPC-157, on one page.
BPC-157 dosing protocol